Latest News and Press Releases
Want to stay updated on the latest news?
- 
                            
Verizon Communications Inc. (NYSE, NASDAQ: VZ) today announced that its Board of Directors has appointed Independent Lead Director Dan Schulman as CEO.
 - 
                            
Verizon Board of Directors declared a quarterly dividend of 69 cents per outstanding share, an increase of 1.25 cents per share from the previous quarter.
 - 
                            
CINCINNATI, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware products and merchandising solutions, announced that...
 - 
                            
Shareholders as at the ex-dividend date of 12 June 2025 will be eligible to receive any potential special dividend distributions relating to Tembo transactions Corresponding record date will be 13...
 - 
                            
TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Gold Candle Ltd. (Private) (the “Company”) is pleased to announce the appointment of Richard (Rick) Howes as Chief Executive...
 - 
                            
Strategic diversification into power infrastructure and cryptocurrencies supports long-term biopharma innovation PROVIDENCE, R.I., April 22, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ:...
 - 
                            
Winter Park, FL, Feb. 19, 2025 (GLOBE NEWSWIRE) -- SRM Entertainment, Inc. (Nasdaq: SRM) (the “Company”) today announced, despite receiving numerous inquiries from investors, SRM Entertainment has...
 - 
                            
CEO of Tevogen Bio, Dr. Saadi addresses short selling and its potential impact on the nation’s health and prosperity. Reaffirms commitment to shareholders.
 - 
                            
KULR announced it has increased its bitcoin purchases for its Bitcoin Treasury by an additional $10 million to reach a total of approximately $60 million i
 - 
                            
WARREN, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...